Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29: e2034. https://doi.org/10.1002/RMV.2034.

Article  PubMed  Google Scholar 

Green ML, Leisenring W, Xie H, Mast TC, Cui Y, Sandmaier BM, et al. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol. 2016;3:e119–27. https://doi.org/10.1016/S2352-3026(15)00289-6.

Article  PubMed  PubMed Central  Google Scholar 

Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney. Transplantation. 2008;46:840–6. https://doi.org/10.1086/528718.

Article  Google Scholar 

Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004;103:2003–8. https://doi.org/10.1182/BLOOD-2003-10-3616.

Article  CAS  PubMed  Google Scholar 

Eberhardt KA, Jung V, Knops E, Heger E, Wirtz M, Steger G, et al. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality. Bone Marrow Transplant. 2023. https://doi.org/10.1038/s41409-023-01944-2.

Article  PubMed  PubMed Central  Google Scholar 

Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients—guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019. https://doi.org/10.1111/CTR.13512.

Article  PubMed  PubMed Central  Google Scholar 

Sergio Azevedo L, Camera Pierrotti L, Abdala E, FigueiredoCosta S, Strabelli TMV, Vidal Campos S, et al. Cytomegalovirus infection in transplant recipients. Clinics. 2015;71:515–23. https://doi.org/10.6061/clinics/2015(07)09.

Article  Google Scholar 

Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Investig. 2011;121:1673–80. https://doi.org/10.1172/JCI45449.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartmann A, Sagedal S, Hjelmesæth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation. 2006;82:S15–7. https://doi.org/10.1097/01.TP.0000230460.42558.B0.

Article  PubMed  Google Scholar 

Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991;325:1601–7. https://doi.org/10.1056/NEJM199112053252303/ASSET/B189B42A-6F5C-49E2-B358-8A8E143911DE/ASSETS/IMAGES/LARGE/NEJM199112053252303_F5.JPG.

Article  CAS  PubMed  Google Scholar 

Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med. 1993;118:173–8. https://doi.org/10.7326/0003-4819-118-3-199302010-00003/ASSET/IMAGES/3TT3.JPG.

Article  CAS  PubMed  Google Scholar 

Ljungman P, Chemaly RF, Khawaya F, Alain S, Avery R, Badshah C, et al. Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the Transplant Associated Virus Infections Forum. Clin Infect Dis. 2024;79:787–94. https://doi.org/10.1093/CID/CIAE321.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotton CN. CMV: prevention, diagnosis and therapy. Am J Transplant. 2013;13:24–40. https://doi.org/10.1111/ajt.12006.

Article  PubMed  Google Scholar 

Chou S. Newer methods for diagnosis of cytomegalovirus infection. Clin Infect Dis. 1990;12:727–36.

Article  Google Scholar 

Ljungman P, de Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e260–72. https://doi.org/10.1016/S1473-3099(19)30107-0.

Article  PubMed  Google Scholar 

Li X, Zhong Y, Qiao Y, Li H, Hu X, Imani S, et al. Advances and challenges in cytomegalovirus detection methods for liver transplant donors. Diagnostics. 2023;2023(13):3310. https://doi.org/10.3390/DIAGNOSTICS13213310.

Article  Google Scholar 

Pang XL, Chui L, Fenton J, LeBlanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol. 2003;41:3167–74. https://doi.org/10.1128/JCM.41.7.3167-3174.2003/ASSET/64E5AED5-FCAB-4ABF-AF79-46145CEA532D/ASSETS/GRAPHIC/JM0731679004.JPEG.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013;26:703–27. https://doi.org/10.1128/CMR.00015-13.

Article  PubMed  PubMed Central  Google Scholar 

Ariza-Heredia EJ, Nesher L, Chemaly RF. Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett. 2014;342:1–8. https://doi.org/10.1016/j.canlet.2013.09.004.

Article  CAS  PubMed  Google Scholar 

Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900–31. https://doi.org/10.1097/TP.0000000000002191.

Article  PubMed  Google Scholar 

Deray KGV, Danziger-Isakov LA, Downes KJ. Current and emerging antiviral agents in the prevention and treatment of cytomegalovirus in pediatric transplant recipients. J Pediatric Infect Dis Soc. 2024;13:S14-21. https://doi.org/10.1093/JPIDS/PIAD059.

Article  CAS  Google Scholar 

Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA. 1987;257:3082–7. https://doi.org/10.1001/JAMA.1987.03390220080025.

Article  CAS  PubMed  Google Scholar 

Preiksaitis JK, Hayden RT, Tong Y, Pang XL, Fryer JF, Heath AB, et al. Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples. Clin Infect Dis. 2016;63:583–9. https://doi.org/10.1093/CID/CIW370.

Article  PubMed  Google Scholar 

El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, et al. The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients. J Infect Dis. 2019;219:898–907. https://doi.org/10.1093/INFDIS/JIY592.

Article  PubMed  Google Scholar 

Crumpacker CS. Mechanism of action of foscarnet against viral polymerases. Am J Med. 1992;92:3S-7S.

Article  CAS  PubMed  Google Scholar 

Metafuni E, Chiusolo P, Sica S, Laurenti L, Bregante S, Teresa M, et al. Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants. Bone Marrow Transplant. 2018;53:1560–7. https://doi.org/10.1038/s41409-018-0200-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piret J, Boivin G. Management of cytomegalovirus infections in the era of the novel antiviral players, letermovir and maribavir. Infect Dis Rep. 2024;16:65–82. https://doi.org/10.3390/idr16010005.

Article  PubMed  PubMed Central  Google Scholar 

Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369:1227–36. https://doi.org/10.1056/nejmoa1303688.

Article  CAS  PubMed  Google Scholar